Jingjiang Yong'an Pharmaceutical Co., Ltd. Independent Director 2025 Annual Performance Report
To all shareholders and shareholder representatives:
I, Guo Xiaohua, was elected as an Independent Director and a member of the Audit Committee of Jingjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") on January 14, 2025, serving on the Seventh Board of Directors. During my tenure, I have strictly abided by the Company Law, the Administrative Measures for Independent Directors of Listed Companies, the Shenzhen Stock Exchange's Self-Regulatory Guidelines No. 1—Code of Conduct for Main Board Listed Companies, and other relevant laws and regulations, as well as the Articles of Association and the Independent Director Work System. I have diligently and faithfully performed my duties, actively attended company meetings, carefully reviewed all proposals, and fully exercised my functions as an independent director to effectively protect the legitimate rights and interests of the Company and all shareholders, especially small and medium shareholders. The report on my performance in 2025 is as follows:
I. Basic Information (I) Work Experience I am Guo Xiaohua, born in 1978, a Chinese national with no permanent overseas residency. I hold a Ph.D. from China Agricultural University and completed postdoctoral research at the National Veterinary Science and Quarantine Institute of the Ministry of Agriculture and Forestry of Korea. I am currently the Vice Dean, Professor, and Doctoral Supervisor of the School of Life Sciences at South-Central Minzu University. I am also a director of the Feed Branch of the China High-Tech Industrialization Research Society, specializing in the basic theory and applied technology research of microecological resources and engineering. I have led 4 National Natural Science Foundation projects, 1 project for serving enterprises in Hubei Province's science and technology sector, 1 Outstanding Youth Talent Project in Hubei Province, 1 startup fund project for returned overseas students from the Ministry of Education, and 1 project that has passed provincial science and technology achievement appraisal. I have also led multiple industry-cooperation projects and applied for and obtained approval for 1 provincial project for cultivating outstanding engineers in collaboration with universities and enterprises. I have published over 40 SCI papers as the first author or corresponding author, including 10 TOP papers. I have obtained 7 national invention patents. Since January 14, 2025, I have served as an Independent Director and a member of the Audit Committee of the Company.
(II) Statement on Independence In 2025, during my tenure, I have not held any positions in the Company other than Independent Director and member of the Audit Committee. I have also not held any positions in the principal shareholder companies of the Company. I have no conflict of interest with the Company or its principal shareholders, nor any other relationship that could hinder my independent and objective judgment. I have independently performed my duties, in compliance with the requirements of the Administrative Measures for Independent Directors of Listed Companies, the Shenzhen Stock Exchange's Code of Conduct for Main Board Listed Companies, and the Articles of Association.
II. Performance of Duties (I) Attendance at Board and Shareholders' Meetings In 2025, during my tenure, the Company held 7 board meetings and 3 shareholders' meetings. My attendance is as follows:
| Independent Director | Annual Attendance | On-site Attendance | Attendance via Communication | Entrusted Voting | Absence | Consecutive Absence | Attendance at Shareholders' Meetings |
|---|---|---|---|---|---|---|---|
| Guo Xiaohua | 7 | 1 | 6 | 0 | 0 | No | 3 |